wet macular degeneration
Showing 1 - 25 of 46
Age-related Macular Degeneration, Macular Degeneration, Wet Macular Degeneration Trial in Germany, Switzerland (Brolucizumab)
Recruiting
- Age-related Macular Degeneration
- +5 more
- Brolucizumab
-
Regensburg, Bavaria, Germany
- +32 more
Jan 20, 2023
Wet Macular Degeneration Trial in Worldwide (Faricimab, Aflibercept, Sham Procedure)
Artificial Intelligence Diagnostic Aid
Not yet recruiting
- Wet Macular Degeneration
- +2 more
- Macusense Assessment Software
-
London, Westminster, United KingdomGuy's and St Thomas's NHS Foundation Trust
Dec 29, 2022
Wet Macular Degeneration Trial in Germany, United Kingdom, United States (BI 836880)
Suspended
- Wet Macular Degeneration
- BI 836880
-
Palo Alto, California
- +13 more
Aug 24, 2022
Wet Macular Degeneration Trial in Prague (Aflibercept 40 MG/ML [Eylea], Brolucizumab-Dbll 120 MG/ML [Beovu], Ranibizumab 6 MG/ML
Withdrawn
- Wet Macular Degeneration
- Aflibercept 40 MG/ML [Eylea]
- +2 more
-
Prague, CzechiaDepartment of Ophthalmology, Faculty hospital Kralovske Vinohrad
Aug 7, 2022
Wet Macular Degeneration Trial in Worldwide (Faricimab, Aflibercept, Sham Procedure)
Retinal Revascularization and Clinical Indicators of Neovascular
Recruiting
- Wet Macular Degeneration
- Ophthalmic Drugs
-
Arendal, Agder, NorwaySorlandet Hospital HF
Mar 3, 2022
Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States
Completed
- Age-related Macular Degeneration
- +2 more
- bevacizumab
- ranibizumab
-
Tucson, Arizona
- +49 more
Feb 15, 2022
Wet Macular Degeneration Trial in Los Angeles (Aflibercept Ophthalmic, optovue angiovue)
Completed
- Wet Macular Degeneration
- Aflibercept Ophthalmic
- optovue angiovue
-
Los Angeles, CaliforniaStein Eye Institute of UCLA
Dec 9, 2021
Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in Springfield,
Active, not recruiting
- Age-Related Macular Degeneration
- +4 more
- bevacizumab
-
Springfield, Illinois
- +2 more
Dec 6, 2021
Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States
Completed
- Age-related Macular Degeneration
- +4 more
- bevacizumab
-
Tucson, Arizona
- +19 more
Nov 16, 2021
Neovascular Age-related Macular Degeneration, Wet Macular Degeneration, Wet Age-related Macular Degeneration Trial in United
Recruiting
- Neovascular Age-related Macular Degeneration
- +2 more
- RGX-314
-
Phoenix, Arizona
- +12 more
Oct 12, 2021
Connective Tissue Growth Factor in Neovascular Age Related
Recruiting
- Wet Macular Degeneration
-
Baltimore, MarylandWilmer Eye Institute at Johns Hopkins University
Sep 3, 2021
Reading Speed Improvements in Wet-AMD Patients After Ranibizumab
Completed
- Ophthalmopathy
- Wet Macular Degeneration
- (no location specified)
Jul 20, 2021
Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in Australia
Completed
- Age-related Macular Degeneration
- +2 more
- bevacizumab
- ranibizumab
-
Hurstville, New South Wales, Australia
- +8 more
May 7, 2021
Choroidal Neovascularization, Wet Macular Degeneration Trial in United States (ICON-1, aflibercept)
Terminated
- Choroidal Neovascularization
- Wet Macular Degeneration
- ICON-1
- aflibercept
-
Beverly Hills, California
- +7 more
Mar 21, 2021
Macular Degeneration, Wet Macular Degeneration Trial in La Jolla (Intravitreal aflibercept injection)
Completed
- Macular Degeneration
- Wet Macular Degeneration
- Intravitreal aflibercept injection
-
La Jolla, CaliforniaShiley Eye Center
Mar 23, 2021
Wet Macular Degeneration Trial in Portugal, Spain (Retilut, Theavit)
Completed
- Wet Macular Degeneration
- Retilut
- Theavit
-
Celas, Coimbra, Portugal
- +8 more
Feb 11, 2021
Age-Related Macular Degeneration, Macular Degeneration, Wet Macular Degeneration Trial in Phoenix, Abilene, Arecibo
Completed
- Age-Related Macular Degeneration
- +5 more
- brolucuzumab 6 mg IVT
-
Phoenix, Arizona
- +2 more
Dec 9, 2020
Wet Macular Degeneration, Wet Age-related Macular Degeneration Trial in Virginia Beach (Ziv-Aflibercept 25 MG/ML [Zaltrap],
Completed
- Wet Macular Degeneration
- Wet Age-related Macular Degeneration
- Ziv-Aflibercept 25 MG/ML [Zaltrap]
- Ranibizumab
-
Virginia Beach, VirginiaWagner Macula & Retina Center
Oct 5, 2020
Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States (Dorzolamide-timolol, Artificial
Completed
- Neovascular Age-related Macular Degeneration
- Wet Macular Degeneration
- Dorzolamide-timolol
- Artificial tears
-
Palo Alto, California
- +4 more
Jun 5, 2020
Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet
Completed
- Wet Macular Degeneration
- Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
-
Multiple Locations, France(unnamed)
Apr 15, 2020
Subfoveal Hemorrhage in Neovascular Age-Related Macular
Terminated
- Submacular Hemorrhage
- +2 more
- Anti-VEGF
- Hemorrhage displacement + Anti-VEGF
-
Baltimore, MarylandWilmer Eye Institute, Johns Hopkins
Feb 17, 2020